FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,162 | -64.7% | 7,154 | 0.0% | 0.00% | – |
| Q2 2023 | $34,482 | -12.4% | 7,154 | 0.0% | 0.00% | – |
| Q1 2023 | $39,347 | -41.8% | 7,154 | -39.5% | 0.00% | – |
| Q4 2022 | $67,599 | -96.5% | 11,818 | -85.6% | 0.00% | -100.0% |
| Q3 2022 | $1,929,000 | -74.0% | 81,848 | -65.3% | 0.00% | -83.3% |
| Q2 2022 | $7,427,000 | -47.5% | 235,693 | -34.1% | 0.01% | -40.0% |
| Q1 2022 | $14,148,000 | -12.0% | 357,539 | -6.2% | 0.01% | 0.0% |
| Q4 2021 | $16,084,000 | -32.1% | 381,134 | -4.6% | 0.01% | -41.2% |
| Q3 2021 | $23,688,000 | -33.2% | 399,654 | -2.2% | 0.02% | -32.0% |
| Q2 2021 | $35,453,000 | – | 408,487 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |